| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Travere Therapeutics, Inc. (TVTX) have been net sellers, shedding 1,304,671 shares worth roughly $80.1M on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
The insider who sold still holds shares after the sale. TVTX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $11.64M | -243,735 | |
| VP | 117.1K | $2.62M | - | |
| Other | 105.4K | $6.88M | - | |
| VP | 100.5K | $6.56M | - | |
| Other | 98.2K | $1.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Heerma Peter53 | Chief Commercial Officer | Sale+OE | 2,174 | $46.65 | $101,417.10 | -1.5% | +22.7% | - | |
| May 4, 2026 | Meckler Jeffrey A45 | Director | Sale+OE10b5-1 | 8,000 | $45.00 | $360,000.00 | -8.4% | +22.4% | - | |
| May 1, 2026 | Baynes Roy D. | Director | Sale+OE10b5-1 | 9,750 | $44.22 | $431,145.00 | -20.6% | +29.8% | - | |
| Apr 22, 2026 | Rote William E.58 | Chief Research Officer | Sell10b5-1 | 9,100 | $39.09 | $355,719.00 | -7.4% | +41.1% | - | |
| Apr 15, 2026 | Reed Elizabeth E57 | Chief Legal Officer and GC | Sale+OE10b5-1 | 51,500 | $41.29 | $2,126,451.68 | -32.9% | +39.3% | - | |
| Apr 15, 2026 | Dube Eric M56 | Chief Executive Officer | Sell10b5-1 | 64,000 | $41.09 | $2,629,975.10 | -12.9% | +39.3% | - | |
| Apr 15, 2026 | Cline Christopher R.48 | Chief Financial Officer | Sell10b5-1 | 8,327 | $41.91 | $348,974.00 | -6.6% | +39.3% | - | |
| Apr 15, 2026 | Inrig Jula | Chief Medical Officer | Sell10b5-1 | 8,233 | $42.01 | $345,893.27 | -6.9% | +39.3% | - | |
| Apr 14, 2026 | Baynes Roy D. | Director | Sale+OE10b5-1 | 32,750 | $41.29 | $1,352,130.00 | -46.6% | +33.6% | - | |
| Apr 14, 2026 | Lyons Gary A54 | Director | Sale+OE10b5-1 | 8,000 | $41.07 | $328,560.00 | -12.2% | +33.6% | - |